| Drug Name: | Nitrous oxide (10024-97-2) |
|---|---|
| PubChem ID: | 948 |
| SMILES: | N#[N+][O-] |
| InchiKey: | GQPLMRYTRLFLPF-UHFFFAOYSA-N |
| Therapeutic Category: | Analgesics, Anesthetics, Central Nervous System Agents, Central Nervous System Depressants, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 44.013 |
| LogP | : | 0.33728 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 51.21 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Methotrexate (59-05-2) | Stomatitis | Additive | the effects of methotrexate on tetrahydrofolate metabolism are increased by nitrous oxide | Toxicity of methotrexate in rats preexposed to nitrous oxide |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category